Medical-grade dermal filler combining high/low molecular weight HA (20mg/ml concentration) for volumetric enhancement. Features patented cross-linking technology with 98.7% hyaluronic acid purity, clinically proven for 12-18 month duration. FDA-registered formula ensures optimal tissue integration and projection maintenance.

Advanced Cross-Linking Technology:

Proprietary HYLACROSS™ formulation enables:
• Stable 3D hydrogel network
• 72% increased G’-value vs standard fillers
• Syringe-extractable without saline dilution
• Natural metabolic absorption profile

Clinical Protocol:

1. Use 18G-22G cannula for deep subdermal placement
2. Maintain 5mm injection depth minimum
3. Maximum 10ml per treatment area
4. Post-treatment massage contraindicated
5. Store at 2-25°C protected from light

Medical Notice: Results may vary ±15% based on metabolic factors. Contains sodium hyaluronate of non-animal origin. Contraindicated for patients with active skin infections or bleeding disorders. Must be administered by licensed practitioners with advanced body contouring certification. Product efficacy validated in 2023 multicenter study (n=142).